» Articles » PMID: 10048435

Therapy-related Myelodysplastic Syndrome in Adults with Neurofibromatosis

Overview
Journal Leuk Lymphoma
Specialties Hematology
Oncology
Date 1999 Feb 27
PMID 10048435
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Although an increased risk of hematologic malignancies in children with Neurofibromatosis-1 (NF-1) is well established, whether adults with NF-1 have an increased risk of such malignancies is unclear. We currently describe two adult patients with NF-1 who rapidly developed secondary myelodysplastic syndromes with abnormalities of chromosome 7 following chemotherapy for AML. We propose that adults with NF-1 also have abnormalities of hematologic progenitor cells.

Citing Articles

A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.

Quintas-Cardama A, Daver N, Kim H, DiNardo C, Jabbour E, Kadia T Clin Lymphoma Myeloma Leuk. 2014; 14(5):401-10.

PMID: 24875590 PMC: 4167474. DOI: 10.1016/j.clml.2014.03.001.


Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.

Sill H, Olipitz W, Zebisch A, Schulz E, Wolfler A Br J Pharmacol. 2010; 162(4):792-805.

PMID: 21039422 PMC: 3042191. DOI: 10.1111/j.1476-5381.2010.01100.x.


Therapy-related myelodysplastic syndrome: models and genetics.

Graubert T Biol Blood Marrow Transplant. 2009; 16(1 Suppl):S45-7.

PMID: 19857585 PMC: 2832708. DOI: 10.1016/j.bbmt.2009.10.019.